III.1 Tamoxifen and the uterus - The hysteroscopic approach

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Van Belle, Y ^a   Campo, R ^a   Neven, P ^a   De Muylder, X ^a   Vanderick, G ^a  

^a Saint Jean Clinic of Brussels   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; CANCER PATIENT; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; ECHOGRAPHY; ENDOMETRIUM ATROPHY; FEMALE; HUMAN; HYSTEROSCOPY; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; UTERUS CAVITY;

EID: 0031715132     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00098-7     Document Type: Conference Paper

References (4)

1. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E. Tamoxifen and the uterus and endometrium. Lancet 1989, i, 375-376.
2. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E. Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynaecol Rep Biol 1990, 35, 235-238.
3. De Muylder X, Neven P, De Somer M, Van Belle Y, Vanderick G, De Muylder E. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 1991, 36, 127-130.
4. Neven P, De Muylder X, Van Belle Y, Van Hooff I, Vanderick G. Longitudinal hysteroscopic follow-up during tamoxifen treatment. Lancet (in press).